Hercules Capital has extracted itself from a difficult credit situation with the sale of a troubled gene therapy portfolio company.
We review the IIIQ 2024 performance of 4 more BDCs that reported their results in the first week of earnings season.
We are writing credit summaries for every BDC that has reported IVQ 2023 results. These summaries accompany one of the BDC Reporter’s top SubScriber Tools: the BDC Credit Table. We have just completed a credit update for Barings BDC. That’s 12 completed.
Hercules Capital has reported its most recent dividend. We analyze the BDC’s payout performance, its sources and discuss what the future may hold.
Hercules Capital is back to increasing its regular distribution after a short hiatus. We discuss the BDC’s recent payout history and speculate on the way forward.
A Middle Eastern investment firm has just acquired a major stake in the largest venture-debt BDC. We offer up what we know.
Fitch gives Hercules Capital a thumbs up.
Hot off The Presses. The leading venture-debt BDC is hooking up with a large asset manager to finance “venture and growth stage” companies. We discuss the implications.
An asset-based lending subsidiary of Hercules Capital is expanding. The BDC Reporter analyzes the move and how the investment has performed over the last 5 years.
Hercules Capital wants its stakeholders to know that the BDC is financially strong, liquid and had no banking relationship with Silicon Valley Bank. As we discuss, this might be a golden opportunity for the BDC, but it might not – depending on the wider fall-out from this crisis.
The BDC Reporter highlights five key take-aways from Hercules Capital’s just announced results.
Hercules Capital continues a multi-quarter, multi-year record of increasing its payouts to shareholders. We review the latest news and the recent numbers.
The BDC Reporter previews what investors might expect from Hercules Capital’s IIQ 2022 results – scheduled to land on July 28.
